Following the label expansion, Sarepta's (SRPT) Elevidys is approved to treat all DMD patients aged four years and older, regardless of ambulation...

MONDAY, June 24, 2024 -- The U.S. Food and Drug Administration has expanded the approval of Elevidys (delandistrogene moxeparvovec-rokl), a gene...

Roche announced that the European Medicines Agency (EMA) has validated and initiated review of the marketing authorisation application (MAA) for...

Australia has cemented its role in becoming a major player in the next generation of medicines with the launch of Ternarx – a globally competitive...

Aethlon Medical, Inc., a medical therapeutic company focused on developing products to treat cancer and life─threatening infectious diseases,...

Barcelona, Spain, June 17, 2024 – Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), one of the world’s leading producers of plasma-derived...

The prognosis for recovery from a spinal cord injury (SCI) is of great importance for those directly affected and those around them.